Fri. Apr 19th, 2024

AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: This really is a representative sample of 20 recent research found on a PubMed query (breast cancer blood miRNA miR) that describe individual miRNAs or miRNA signatures possessing potential application for early illness detection. Studies with fewer than 20 BC instances have been excluded. Although these signatures primarily reflect greater amounts of circulating miRNAs, some miRNAs are detected at decrease levels in blood samples of BC sufferers. Blood collection was performed before surgery unless otherwise GSK3326595 biological activity indicated. miRNAs shown in bold indicate a recurrent presence in at the very least three independent research. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two miRNArelated risk loci related to BCGene locus MIR27A SNP rs895919 *C Comments Population Asians Caucasians Jewish BRCA2 carriers GSK2879552 Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No threat association Protective dar.12324 increased threat Decreased risk No danger association Decreased danger Decreased threat Decreased threat No danger association No threat association increased survival No risk association Decreased overall danger enhanced threat enhanced threat No danger association elevated general risk Decreased danger of eR+ BC No danger association earlier age of onset No threat association No threat association No threat association No threat association Decreased risk (C allele) No danger association No danger association No risk association No threat association No threat association No risk association No threat association No threat association Reduced threat Decreased threat Survival of HeR2+ instances No danger association Decreased threat No risk association Decreased risk Decreased threat Decreased risk enhanced risk improved risk No danger association No threat association No threat association No risk association Decreased threat of eR- BC No risk association enhanced survival increased risk of eR- BC No risk association No danger association improved all round risk No risk association No danger association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Principal transcript Principal transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: That is a representative sample of 20 recent studies located on a PubMed query (breast cancer blood miRNA miR) that describe person miRNAs or miRNA signatures possessing prospective application for early disease detection. Studies with fewer than 20 BC circumstances were excluded. Even though these signatures mainly reflect greater amounts of circulating miRNAs, some miRNAs are detected at decrease levels in blood samples of BC patients. Blood collection was performed ahead of surgery unless otherwise indicated. miRNAs shown in bold indicate a recurrent presence in no less than 3 independent studies. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable 2 miRNArelated danger loci associated with BCGene locus MIR27A SNP rs895919 *C Comments Population Asians Caucasians Jewish BRCA2 carriers Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No danger association Protective dar.12324 improved danger Decreased threat No risk association Decreased risk Decreased danger Decreased danger No danger association No risk association improved survival No risk association Decreased general risk elevated threat enhanced threat No risk association increased overall risk Decreased risk of eR+ BC No threat association earlier age of onset No threat association No threat association No danger association No risk association Decreased threat (C allele) No risk association No risk association No risk association No risk association No danger association No risk association No threat association No danger association Reduced risk Decreased risk Survival of HeR2+ cases No danger association Decreased danger No risk association Decreased risk Decreased risk Decreased threat elevated threat enhanced risk No threat association No risk association No threat association No risk association Decreased danger of eR- BC No risk association increased survival increased danger of eR- BC No danger association No threat association elevated all round threat No threat association No risk association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Primary transcript Main transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.